APA (7th ed.) Citation

Kumarathurai, P., Anholm, C., Nielsen, O. W., Kristiansen, O. P., Mølvig, J., Madsbad, S., . . . Sajadieh, A. (2016). Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: A randomized double-blind placebo-controlled crossover study. Cardiovascular diabetology, 15(1), 105. https://doi.org/10.1186/s12933-016-0425-2

Chicago Style (17th ed.) Citation

Kumarathurai, Preman, Christian Anholm, Olav W. Nielsen, Ole P. Kristiansen, Jens Mølvig, Sten Madsbad, Steen B. Haugaard, and Ahmad Sajadieh. "Effects of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide on Systolic Function in Patients with Coronary Artery Disease and Type 2 Diabetes: A Randomized Double-blind Placebo-controlled Crossover Study." Cardiovascular Diabetology 15, no. 1 (2016): 105. https://doi.org/10.1186/s12933-016-0425-2.

MLA (9th ed.) Citation

Kumarathurai, Preman, et al. "Effects of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide on Systolic Function in Patients with Coronary Artery Disease and Type 2 Diabetes: A Randomized Double-blind Placebo-controlled Crossover Study." Cardiovascular Diabetology, vol. 15, no. 1, 2016, p. 105, https://doi.org/10.1186/s12933-016-0425-2.